Boai NKY Medical Holdings Ltd
SZSE:300109
Intrinsic Value
Boai NKY Medical Holdings Ltd. engages in the operation of pharmaceutical excipients, polyvinylpyrrolidone series products and vinyl methyl ether and maleic anhydride polymer products. [ Read More ]
The intrinsic value of one
Boai NKY Medical Holdings Ltd
stock under the Base Case scenario is
26.96
CNY.
Compared to the current market price of 22.24 CNY,
Boai NKY Medical Holdings Ltd
is
Undervalued by 17%.
Boai NKY Medical Holdings Ltd's market capitalization is 7B CNY.
Boai NKY Medical Holdings Ltd stock price is 22.24 CNY.
Boai NKY Medical Holdings Ltd stock price (22.24 CNY) is 17% less than its Intrinsic Value (26.96 CNY).
Boai NKY Medical Holdings Ltd stock (21.31 CNY) is 4% less than its price (22.24 CNY). Open DCF Valuation
Boai NKY Medical Holdings Ltd stock price (22.24 CNY) is 32% less than its Relative Value (32.6 CNY). Open Relative Valuation
Boai NKY Medical Holdings Ltd has upside potential of 18% compared to the average analyst price target.
Open Wall St Estimates
Boai NKY Medical Holdings Ltd's Revenue has grown by 5% over the past 12 months.
Boai NKY Medical Holdings Ltd has positive three-year average ROE (Return on Equity): 9%. The company is efficient at transforming stockholders' equity into net income.
Boai NKY Medical Holdings Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 14%.
Boai NKY Medical Holdings Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 15%.
Boai NKY Medical Holdings Ltd has positive Free Cash Flow for the last twelve months.
Boai NKY Medical Holdings Ltd has positive three-year average ROIC (Return on Invested Capital): 7%. The company is efficient at using invested capital to generate operating income.
Boai NKY Medical Holdings Ltd has positive Net Income for the last twelve months.
Boai NKY Medical Holdings Ltd's ROE (Return on Equity) has significantly increased in the last 3 years from 3% to 15%.
Boai NKY Medical Holdings Ltd's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from 2% to 14%.
Boai NKY Medical Holdings Ltd has positive Operating Income for the last twelve months.
Boai NKY Medical Holdings Ltd's Revenue has been growing by 16% per year for the last 3 years.
Boai NKY Medical Holdings Ltd has negative Net Debt. This means that the company has more cash and short-term investments (289m CNY) than debt (204m CNY).
Boai NKY Medical Holdings Ltd has positive Gross Profit for the last twelve months.
Boai NKY Medical Holdings Ltd's short-term assets (1B CNY) exceed its short-term liabilties (427m CNY).
Boai NKY Medical Holdings Ltd's D/E (Debt to Equity) is very low and is equal to 0.06.
Boai NKY Medical Holdings Ltd's long-term assets (4B CNY) exceed its long-term liabilties (474m CNY).
Boai NKY Medical Holdings Ltd's Altman Z-Score is very high and is equal to 9.07.
Valuation Backtest
Boai NKY Medical Holdings Ltd
Run backtest to discover the historical profit from buying and selling
Boai NKY Medical Holdings Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Boai NKY Medical Holdings Ltd
Balance Sheet Decomposition
Boai NKY Medical Holdings Ltd
| Current Assets | 1.2B |
| Cash & Short-Term Investments | 289.1m |
| Receivables | 507m |
| Other Current Assets | 390.9m |
| Non-Current Assets | 2.8B |
| Long-Term Investments | 868.3m |
| PP&E | 1.3B |
| Intangibles | 489.7m |
| Other Non-Current Assets | 130.1m |
| Current Liabilities | 426.9m |
| Accounts Payable | 135.1m |
| Accrued Liabilities | 32.8m |
| Short-Term Debt | 171.2m |
| Other Current Liabilities | 87.9m |
| Non-Current Liabilities | 46.8m |
| Long-Term Debt | 32.6m |
| Other Non-Current Liabilities | 14.1m |
Earnings Waterfall
Boai NKY Medical Holdings Ltd
|
Revenue
|
1.6B
CNY
|
|
Cost of Revenue
|
-737.9m
CNY
|
|
Gross Profit
|
877.2m
CNY
|
|
Operating Expenses
|
-309.3m
CNY
|
|
Operating Income
|
568m
CNY
|
|
Other Expenses
|
-73.5m
CNY
|
|
Net Income
|
494.4m
CNY
|
Free Cash Flow Analysis
Boai NKY Medical Holdings Ltd
Profitability Score
Profitability Due Diligence
Boai NKY Medical Holdings Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
Boai NKY Medical Holdings Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Boai NKY Medical Holdings Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Score
Boai NKY Medical Holdings Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Boai NKY Medical Holdings Ltd
According to Wall Street analysts, the average 1-year price target for
Boai NKY Medical Holdings Ltd
is 26.15 CNY
.
Shareholder Return
Price
Boai NKY Medical Holdings Ltd
| Average Annual Return | 14.77% |
| Standard Deviation of Annual Returns | 31.65% |
| Max Drawdown | -60% |
| Market Capitalization | 7B CNY |
| Shares Outstanding | 306 309 475 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Boai NKY Medical Holdings Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Boai NKY Medical Holdings Ltd. engages in the operation of pharmaceutical excipients, polyvinylpyrrolidone series products and vinyl methyl ether and maleic anhydride polymer products. The company is headquartered in Jiaozuo, Henan and currently employs 992 full-time employees. The company went IPO on 2010-08-25. The Company’s main products include GBL, 2- pyrrolidone, N-vinylpyrrolidone (NVP) monomer, PVP-K series (PVPK), polyvinylpolypyrrolidone (PPVP), PVP- Iodine (PVP-I), related pharmaceutical intermediates and others. The firm's products are mainly used in daily chemical, medicine, liquor and beverage, pigments and coatings, textile, paper making, oil extraction, sensitive material, electronic and other industries. The firm distributes its products in domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one
Boai NKY Medical Holdings Ltd
stock under the Base Case scenario is
26.96
CNY.
Compared to the current market price of 22.24 CNY,
Boai NKY Medical Holdings Ltd
is
Undervalued by 17%.
You don't have any saved screeners yet
